How the Novavax coronavirus vaccine uses moth cells

Novavax, a biotech company in Gaithersburg, Md., uses recombinant protein technology to create their coronavirus vaccine. It has been highly anticipated by many experts, because it would add a more traditional technology to the portfolio of coronavirus vaccines in the United States.

Other vaccines work by instructing the body’s cells to build the spiky proteins that dot the outside of the coronavirus. The immune system learns from the exposure to recognize the real thing. But Novavax’s vaccine consists of that spike protein, generated inside insect cells that grow in giant bioreactors. The approach is innovative, but protein-based vaccines have been used for decades, including one for hepatitis B. Read more: https://wapo.st/2Sx26wc. Subscribe to The Washington Post on YouTube: https://wapo.st/2QOdcqK

Follow us:
Twitter: https://twitter.com/washingtonpost
Instagram: https://www.instagram.com/washingtonpost/
Facebook: https://www.facebook.com/washingtonpost/

Видео How the Novavax coronavirus vaccine uses moth cells канала Washington Post